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Abstract 
Background: Several platforms have been used to generate the primary data for microsatellite analysis of malaria 
parasite genotypes. Each has relative advantages but share a limitation of being time- and cost-intensive. A com-
mercially available automated capillary gel cartridge system was assessed in the microsatellite analysis of Plasmodium 
vivax diversity in the Peruvian Amazon.
Methods: The reproducibility and accuracy of a commercially-available automated capillary system, QIAxcel, was 
assessed using a sequenced PCR product of 227 base pairs. This product was measured 42 times, then 27 P. vivax sam-
ples from Peruvian Amazon subjects were analyzed with this instrument using five informative microsatellites. Results 
from the QIAxcel system were compared with a Sanger-type sequencing machine, the ABI PRISM® 3100 Genetic 
Analyzer.
Results: Significant differences were seen between the sequenced amplicons and the results from the QIAx-
cel instrument. Different runs, plates and cartridges yielded significantly different results. Additionally, allele size 
decreased with each run by 0.045, or 1 bp, every three plates. QIAxcel and ABI PRISM systems differed in giving differ-
ent values than those obtained by ABI PRISM, and too many (i.e. inaccurate) alleles per locus were also seen with the 
automated instrument.
Conclusions: While P. vivax diversity could generally be estimated using an automated capillary gel cartridge system, 
the data demonstrate that this system is not sufficiently precise for reliably identifying parasite strains via microsatel-
lite analysis. This conclusion reached after systematic analysis was due both to inadequate precision and poor repro-
ducibility in measuring PCR product size.
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Background
Molecular markers are widely used in the study of 
malaria and other infectious diseases [1]. Such markers 
allow for the differentiation of new and recurrent infec-
tions, tracing spread of clones of a pathogenic microor-
ganism and discovering new introductions of infection 
on scales both large and small [2–5]. Molecular markers 
allow for genetic diversity studies of pathogen popula-
tions, their substructure and relationships among those 
sub-populations. Such data underpin fine scale analysis 
of infectious disease transmission dynamics [6–13], and 
allow us to infer the disease history and pathogen migra-
tion patterns, of particular importance in current malaria 
control- and elimination-focused research [14–17].
Different methods and markers have been used to study 
Plasmodium genetic diversity and population struc-
ture. A key feature of such studies is that various marker 
types evolve at different rates, being driven by complex 
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mechanisms [10]. With regard to Plasmodium vivax, 
markers have included PCR–restriction fragment length 
polymorphism (PCR–RFLP) using a variety of genes 
including PvCSP, PvMSP3-α [18–20] and PvMSP3-β 
[8, 9, 19–23]. Another marker type is based on DNA 
sequence and single nucleotide polymorphisms (SNPs), 
which have been emphasized for global comparisons [15, 
16, 24]. In recent years, parasite microsatellites markers 
have been used specifically to assess population diversity 
and structure [10–13, 25, 26], because large numbers of 
such markers are present in Plasmodium falciparum and 
P. vivax genomes [24, 27–29]. Microsatellites are pre-
sumed to be neutral if they are not physically linked to 
genes under selection [30–32], and have sufficiently high 
mutation rates to allow for the identification of epide-
miologically relevant diversification events over relatively 
short periods of time [10].
While different platforms and techniques have been 
used to generate the raw data for microsatellite geno-
typing, they tend to be expensive. Costs include fluoro-
phore-labelled primers and a capillary electrophoresis 
platform, typically a Sanger-type sequencing machine. 
In this study, the precision and reproducibility of the 
QIAxcel Advanced System from Qiagen [33] was evalu-
ated using a well-characterized, gold standard sequenced 
PCR product followed by analysis of 271 P. vivax-infected 
blood samples from subjects living in the Peruvian 
Amazon. This platform was chosen based on reported 
performance characteristics primarily because fluo-
rophore-labelled primers were not needed (hence the 
potential for cost saving). The main conclusion of this 
work, based on exhaustive analysis, should be a caution-
ary message for resource-limited settings, where reliance 
on hardware must be presaged by proper performance 
validation prior to investment of resources.
Methods
Ethical considerations
This study was approved by the Human Subjects Protec-
tion Program of the University of California, San Diego 
and the Comité de Ética of the Universidad Peruana Cay-
etano Heredia. Subjects provided written informed con-
sent to participate in the study.
Plasmodium vivax samples
Samples for this study were obtained from three rural vil-
lages in the Peruvian Amazon region of Iquitos, Peru, in 
the Loreto Department, between 2005 and 2008: Santo 
Tomás (latitude −3.8094, longitude −73.3419,), San 
José de Lupuna (latitude −3.74611, longitude −73.3256) 
and Padrecocha (latitude −3.6997, longitude −73.2786). 
Rural communities are located 9.8, 9.9 and 21.1 km from 
Iquitos, respectively (main urban area in the region); San 
José de Lupuna and Padrecocha are accessible only by 
boat (Fig. 1).
Malaria diagnosis was carried out by microscopy using 
standard methods; for this reason only individuals with 
patent P. vivax parasitaemia were included in the study. 
Blood was obtained by venipuncture into EDTA tubes. 
Blood samples were frozen at −20  °C and shipped on 
dry ice to Universidad Peruana Cayetano Heredia, Lima, 
Peru for laboratory analysis. All individuals that tested 
positive were treated with primaquine (1  week, 15  mg/
kg daily plus chloroquine) according to policies of the 
National Malaria Control Programme, Peruvian Ministry 
of Health.
Accuracy, repeatability and reproducibility
One pGEM T-Easy plasmid containing a region of gene 
Pf 18 S rRNA was amplified by PCR using forward primer 
PL1473F18 [5′-TAA CgA ACg AgA TCT TAA-3′] and 
reverse primer PL1679R18 [5′-gTT CCT CTA AgA 
AgC TTT-3′] [34]. This PCR product was sequenced 
on the ABI PRISM 3100 Genetic Analyzer, then run 42 
times in 42 different plates among four different car-
tridges on the QIAxcel Advanced System machine. In 
this way data obtained from sequencing and from the 
QIAxcel Advanced System machine were compared to 
assess reproducibility. Statistical analysis was done using 
STATA 12 (College Station, TX, USA). Student’s T test 
was used to test differences among outputs from differ-
ent runs, plates and cartridges used on the QIAxcel plat-
form, and to test differences between the QIAxcel with 
the reference gold standard method ABI PRISM 3100 
Genetic Analyzer. To measure the effect of cartridge use 
on the outputs, a generalized linear mixed regression 
analysis was made [35]. To test whether the variance of 
the results from the QIAxcel machine was greater than 
expected compared to the ABI PRISM System, a one 
sample test of variance was used [36], assuming a maxi-
mum value of the standard deviation of the ABI PRISM 
system of 0.5 base pairs; additionally, the test was also 
run assuming a maximum standard deviation of one 
base pair. Finally, the accuracy of this QIAxcel platform 
was measured using five different microsatellite targets 
on 27 P. vivax samples. Three microsatellites (MS4, MS9 
and MS15) were non-degenerate or perfect, indicating a 
unique motif repeat. The other two microsatellites were 
imperfect with mixed motifs; combination between dis-
continuous motifs, that are trunked with non-repetitive 
regions, and compounds motifs, with two or more dif-
ferent motifs. Each PCR product was analyzed in both 
platforms the QIAxcel Advanced System machine and 
the ABI PRISM system, and three replicates of MS9 and 
MS15 were done. Results differences between platforms 
were tested using Student’s T test in STATA 12.
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Microsatellite genotyping
Genomic DNA was isolated from whole blood using the 
QIAamp DNA Blood Kit (QIAGEN, Valencia, CA, USA). 
Samples were genotyped using a set of 15 previously 
reported microsatellite markers [37, 38]. Five micros-
atellites were used to genotype 27 samples in a test for 
accuracy (MS4, MS6, MS9, MS15 and MS20), and all 
microsatellites were used to measure genetic diversity 
using 271 P. vivax samples (primers are listed in Addi-
tional file 1). Five microliters of template DNA was used 
for PCR in a 50 μl total volume for each individual reac-
tion. The PCR product was then separated on a QIAxcel 
Advanced System (QIAGEN). The QIAxcel Advanced 
System from Qiagen is commercially presented as a novel 
means to replace gel analysis of DNA, RNA, and pro-
teins. It consists of 12 independent capillaries placed in 
a cartridge. Each cartridge allows processing about 100 
samples per capillary and 96 samples per PCR plate. This 
system is marketed to have a resolution of 3–5  bp. The 
PCR product sizes were estimated using the QIAxcel 
ScreenGel Software.
Capillary electrophoresis analysis
Electrophoresis runs on the QIAxcel Advanced System 
(QIAGEN) were performed according to manufacturer’s 
recommendations. For each electrophoresis process, 
a QIAxcel DNA High Resolution Cartridge (Cat. no. 
929002), a QX Alignment Marker 15 bp/600 bp (Cat. no. 
929530), a standard QX DNA size marker 25–500 pb v2.0 
(Cat. no. 929560), and the OM 700 method, were used. 
Each cartridge was calibrated using QX Intensity Cali-
bration Marker (cat. no. 929500) for its first use. Because 
five plates were processed per day (40 runs), the Separa-
tion buffer, the Wash buffer and the Alignment Marker 
on the buffer tray were renewed every day. The first well 
(position A1) of each plate was filled with 20 μl of one-
twentieth dilution of the standard QX DNA Size Marker 
25–500 bp. The second well (position A2) was filled with 
Pf 18s rRNA PCR product as a reference control. The 
estimated size of this product was used to confirm or cor-
rect the size of the samples between plates. The third and 
fourth well was filled with the positive and negative PCR 























Fig. 1 Map of the study sites
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monoclonal sample with high parasitaemia used to con-
firm the effectiveness of the PCR. It was also used to see 
the presence of non-specific and stutters products. Addi-
tionally, this product also helped to correct the inferred 
size of the samples.
ABI PRISM system electrophoresis runs were carried 
out using a 4-capillary array of 36  cm in combination 
with 3130 POP-4TM Polymer. The GeneScan 500 LIZ 
dye was used as Size Standard, and primers were labelled 
with 6FAM, VIC, NED and PET dyes. Each plate well was 
filled with 0.25 μl of GeneScan 500 Liz, 9.25 μl of Hi-Di 
Formamide, and 1  μl of one-tenth dilution of the PCR 
product. A monoclonal sample was used as positive con-
trol, and Human DNA as negative control.
Microsatellite analysis
The PCR product sizes were estimated using the QIAxcel 
ScreenGel Software and the GeneMapper v3.0 for QIAx-
cel and ABI PRISM results, respectively. Peaks with more 
than 50 RFU (Relative fluorescence units) in the electro-
pherogram were interpreted as alleles, and if additional 
peak of at least one-third the height of the predominant 
peak was seen it was also scored as allele. Finding more 
than one allele was interpreted as a polyclonal infection 
containing two or more genetically distinct clones in 
the same sample. Missing data (no amplifications) was 
reported by loci but were not considered here for defin-
ing haplotypes.
Microsatellite data were entered and cleaned using 
Microsoft Excel, then formatted using an Excel comple-
ment called GenAlEx 6.501 [39]. The expected heterozy-
gosity (He) parameter was estimated, defined as:
 
where n is the number of isolates analyzed and pi is the 
frequency of the ith allele (i = 1,…, L) in the population 
[40].
Expected heterozygosity (He) gives the average prob-
ability that a pair of alleles randomly selected from the 
population is different. Haplotypes, described as unique 
allelic combinations of the 15 loci analyzed, were deter-
mined in monoclonal samples using GenAlEx.
Results
Accuracy, repeatability and reproducibility of the QIAxcel 
Advanced Capillary System
A sequenced PCR product of 227 base pairs (Additional 
file  2) was run 42 times in four different cartridges (5, 
13, 13, and 11 times per each cartridge) on the QIAxcel 
Advanced System, giving a mean value of 223.619 base 
pair (SD  =  1.62229), and a range from 220 to 226  bp. 








There were significant differences between the sequenced 
values and the results from the QIAxcel Advanced System 
(Student’s t test, p =  0.0029). Moreover, there were sig-
nificant differences between different runs, plates and car-
tridges (Student’s t test, p = 0.0275) (Fig. 2). Additionally, 
18 samples were run at least five times in the same run to 
test reproducibility among capillaries. Using the ‘one sam-
ple test of variance’ showed significant differences even at 
a maximum standard deviation value of 1 (p = 0.0003).
The effect of the time of use of each cartridge was 
explored by using a mixed linear regression analysis. A 
statistically significant decrease of -0.0449 base pairs 
from one run to the next (95  % CI −0.0533 to −0.0365) 
was observed in the allele size each time a sample was 
evaluated; and a decrease of −0.3595 base pairs (95 % CI 
−0.4267 to −0.2922) was found each time a plate was run. 
Furthermore, from the four cartridges used, the results 
given by the second cartridge were −2.657 base pairs (95 % 
CI −3.447 to −1.868) lower than those given by the first 
one (Fig. 3). In the case of the third and fourth cartridges 
the results were −1.042 (95 % CI −1.832 to −0.252) and 
−1.387 (95 % CI −2.21 to −0.565) lower, respectively.
Comparing analysis of five microsatellites (MS4, MS6, 
MS9, M15 and MS20) from 27 samples, the automated 
QIAxcel advanced system showed higher size values than 
those obtained by the ABI PRISM system. On average, 
QIAxcel’s size values were 7.022 base pairs higher (95 % 
CI 6.34–7.7). To test if differences between platforms 
were due to the label of primers, MS9 and MS15 were 
analyzed using both kind of primers in triplicates, and 
no significant differences were seen in MS9 products; 
however, significant differences were seen in MS15 prod-
ucts (p value <0.0001). The numbers of alleles for MS4, 
MS6, MS9, MS15 and MS20 on the ABI PRISM system 
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Cartridge
Fig. 2 Distribution of the results of the sequenced PCR product, run 
42 times in four different cartridges
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allele numbers on the QIAxcel system were 7, 6, 5, 4 and 
8, respectively (summarized in Table 1; complete results 
in Additional file 3). Three of the 27 samples were poly-
clonal by ABI PRISM, but only two were detected as 
such by the QIAxcel system. Analysis of microsatellites 
MS6 and MS20 detected all polyclonal samples using 
the ABI PRISM system, while MS15 was not. The other 
two markers did not detect any polyclonal sample. On 
the QIAxcel system only microsatellite MS15 was able to 
detect the polyclonal samples.
Analysis of Plasmodium vivax samples from the Peruvian 
Amazon
A total of 271 P. vivax single infection samples were ana-
lyzed using samples obtained from three rural commu-
nities around Iquitos (Padrecocha, San José de Lupuna 
and Santo Tomás) from the years 2005 and 2008. In 
Padrecocha, 50 blood samples were taken in the year 
2005; 50 blood samples were available from 2006. In San 
José de Lupuna, 15 blood samples obtained in 2006; 35 
blood samples were from 2007; 20 blood samples were 
from 2008. From Santo Tomás, 40 blood samples were 
obtained in 2006; 30 blood samples in 2007; and 31 blood 
samples in 2008 (Table 2).
Estimation of Plasmodium vivax genetic diversity
Two-hundred and seventy-one P. vivax samples were 
genotyped using the automated QIAxcel Advanced Sys-
tem machine. Of the 271 P. vivax samples, 49 samples 
were polyclonal; 13 (15  %) polyclonal infections were 
found in Padrecocha, 14 (25 %) in San José de Lupuna 
and 22 (28  %) in Santo Tomás (Table  2). Moreover, of 
the 222 monoclonal samples, 141 amplified all loci, 53 
showed one null allele, 22 showed two null alleles, five 
showed three null alleles, and just one sample did not 
amplify 14 loci out of the 15 loci analyzed (Table 3).
Because of the insufficient accuracy and reproduc-
ibility obtained using the QIAxcel Advanced System, the 
base pair size result was transformed into an allele pro-
file and coded. In this way, all base pair size results were 
ranked by size and a frequency histogram was made per 
each locus. Base pair sizes with consecutive results (for 
example, 242, 243, 244, 245, 246  bp) were grouped into 
one unique allele based on frequency (Fig. 4). There were 
some base pair size results that were in the middle of two 
alleles and hence could not be defined. Each base pair 
size result that was not defined was labelled as zero or 
a null allele. As a result, of the 222 monoclonal samples, 
103 samples had at least one undefined allele and just 72 
samples had a complete profile (Table  3). Most micros-
atellites except MS4, MS5, MS15, and PV6635 lacked at 
least 5  % of possible data (MS16 presented the highest 






















Fig. 3 Effect of the time of use on the outcome obtained from the 
QIAxcel Advanced System. Y-axis is the result of the QIAxcel (the 
results of the sequenced product) with four different cartridges, and 
the X-axis is the time order of each plate which was ran in the QIAx-
cel. T is the time order of the plate in each cartridge and −0.36 is its 
effect on the outcome. C2, C3 and C4 are the second, third and fourth 
used cartridges and the values represent their effect on the outcome 
in respect to the first cartridge
Table 1 Comparison of results using QIAxcel vs. ABI PRISM methods
The table shows the base pair size of each allele. In parentheses the frequencies of each allele are denoted
Allele MS4 MS6 MS9 MS15 MS20
ABI QIAxcel ABI QIAxcel ABI QIAxcel ABI QIAxcel ABI QIAxcel
1 187 (0.19) 190 (0.08) 210 (0.63) 219 (0.39) 147 (0.19) 156 (0.19) 243 (0.69) 247 (0.24) 200 (0.1) 209 (0.04)
2 193 (0.63) 191 (0.08) 229 (0.33) 220 (0.18) 155 (0.04) 165 (0.11) 249 (0.14) 248 (0.45) 206 (0.2) 210 (0.07)
3 200 (0.19) 192 (0.04) 221 (0.07) 157 (0.11) 166 (0.04) 258 (0.17) 254 (0.14) 220 (0.07) 211 (0.04)
4 197 (0.32) 233 (0.04) 163 (0.67) 172 (0.60) 262 (0.17) 222 (0.63) 216 (0.15)
5 198 (0.36) 237 (0.14) 173 (0.07) 218 (0.04)
6 203 (0.08) 238 (0.18) 221 (0.04)
7 204 (0.04) 230 (0.44)
8 231 (0.19)
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The He index of samples from each geographical 
source of sample was 0.744 ±  0.039, 0.734 ±  0.056 and 
0.716 ±  0.052, for Padrecocha, San José de Lupuna and 
Santo Tomas, respectively; He for the whole population 
was 0.779 ± 0.04. Microsatellite MS7 showed the lowest 
diversity in the whole population (He = 0.375) as well as 
in the three different locations (He for MS7 in Padreco-
cha, San José de Lupuna and Santo Tomás was 0.536, 
0.170, and 0.296, respectively). MS5 showed low diver-
sity (He = 0.539, 0.343 and 0.399, respectively); however, 
its diversity was higher among the whole population 
(He  =  0.621). Microsatellites MS3 and MS1 showed a 
similar patterns. Microsatellites MS16, MS9 and MS8 
showed the highest genetic diversity among localities 
and in the whole population (average He = 0.92, 0.91 and 
0.902, respectively). Moreover, many of the alleles from 
the different markers used were in low frequency (fre-
quency lower than 5 %, referred as minor allele frequency 
or MAF, Table 4).
Among the 72 monoclonal infections with complete 
profiles, 62 haplotypes were found, of which 53 had 
unique haplotypes. None of the haplotypes were shared 
among the three populations, but one haplotype was 
shared in San José de Lupuna between the years of 2007 
and 2008.
Discussion
This study aimed to explore the utility of a non-fluoro-
phore-dependent, automated microsatellite analysis sys-
tem that purportedly had two major advantages—higher 
throughput and lower cost—to obtain raw microsatellite 
marker data. However, the use of microsatellite data, like 
that of other markers [22], requires high precision and 
reproducibility. Hence, any platform used to generate 
Table 2 Number of  monoclonal and  polyclonal samples 
by study site
Locality Year Monoclonal Polyclonal Total
Padrecocha 2005 43 (86 %) 7 (14 %) 50
2006 44 (88 %) 6 (12 %) 50
Total 87 (87 %) 13 (13 %) 100
San Jose de Lupuna 2006 14 (93 %) 1 (7 %) 15
2007 26 (74 %) 9 (26 %) 35
2008 16 (80 %) 4 (20 %) 20
Total 56 (80 %) 14 (20 %) 70
Santo Tomas 2006 30 (75 %) 10 (25 %) 40
2007 26 (87 %) 4 (13 %) 30
2008 23 (74 %) 8 (26 %) 31
Total 79 (78 %) 22 (22 %) 101
Total 222 (82 %) 49 (18 %) 271
Table 3 Number of missing data in each study site




Padrecocha San Jose de Lupuna Santo Tomas Total
Null alleles Undefined 
alleles
Null alleles Undefined 
alleles
Null alleles Undefined 
alleles




0 54 47 48 32 39 40 141 119 72 (32.4)
1 23 22 6 18 24 29 53 69 72 (32.4)
2 7 9 2 6 13 7 22 22 49 (22.1)
3 3 6 0 0 2 1 5 7 16 (7.2)
4 0 1 0 0 0 2 0 3 9 (4.1)
5 0 2 0 0 0 0 0 2 3 (1.4)
14 0 0 0 0 1 0 1 0 1 (0.5)




































Fig. 4 Allele assignments. Displayed are the frequencies of the 
different products obtained for microsatellite MS1 by the QIAxcel 
Advanced System, and its assignment to alleles. The product 237 
was defined as allele 1 since it was separated by five bases from the 
product 242. The products from 242 to 246 were defined as allele 2 
because these products were consecutive and the frequency rise 
from 242 to 244, and then it decrease at 246. The products from 248 
to 250 were defined as allele 3; and the product 247 was labelled as 
undefined since it could be assigned to allele 2 as well as to allele 3
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primary molecular marker data must be able to differen-
tiate alleles of close but non-identical size, such as those 
in the present study that differ in size by 3 bp or less. The 
QIAxcel Advanced System did not demonstrate suffi-
cient reproducibility or accuracy (i.e., to measure the bp 
of a sequenced PCR product (range of ±3 base pairs)) to 
enable accurate data interpretation. These results were 
largely similar to previous (but smaller scale) studies [41]. 
The data provided here was based on comparison of a 
gold standard—a sequenced 227  bp PCR product—and 
using a sequencing gel measurement as a benchmark. 
This PCR product did not show any stutter or non-spe-
cific product, errors which are common in microsatel-
lite analysis. Therefore, with microsatellite products with 
genotyping errors (i.e., stutters, additionally added ade-
nines, non-specific peaks) the range of variation could be 
higher as the presence of stutters could affect the migra-
tion patterns of molecules on the capillary electrophore-
sis. In this sense, most of the degenerated microsatellite 
markers used in this study showed a great number of 
non-specific products, especially MS8 which showed 
four to six non-specific products near the principal allele 
peak.
Discrepancies between ABI PRISM and QIAxcel 
results were also seen. Twenty seven samples were geno-
typed by both platforms using five microsatellites mark-
ers. QIAxcel not only gave different product sizes than 
those observed on the ABI PRISM, but more, inaccurate 
alleles per locus were produced, which altered poten-
tial data interpretation (Additional file  3). Even though 
results were different, they were correlated between each 
other and those additional alleles observed were easily 
detected and edited to its correct allele size. However, 
when more replicates were done the variation of results 
increase, making more difficult to assign the correct 
value (Additional file  4). Differences between labelled 
and non-labelled products were seen too, but it was no 
as high as differences between QIAxcel and ABI platform 
(Additional files 5, 6). This heterogeneity of results was 
reflected in the analysis of the 271 samples. This analysis 
resulted in high diversity of markers and high number of 
alleles per locus. Though most markers were supposed to 
differ in three base pairs, differences in just one base pair 
were usually seen. The error produced by the QIAxcel 
Advanced System was reduced by transforming raw data 
to allele profile codes. Even though the expected He in 
each locality was lower and probably more accurate using 
the transformation (i.e., more lumping, less splitting), the 
genetic diversity of the three localities found in this study 
was somewhat higher than previously reported in the 
same region using the same markers but standard meth-
ods based on fluorophore-labelled primers [11, 25, 42].
Another limitation to the generalizability of the results 
presented here is the high rate of missing data that was 
found in 13 microsatellite markers. A particular case was 
MS16, which showed that 18 % of data points were miss-
ing (72  % due to null alleles), higher than for the other 
microsatellites. This result possibly suggests that a muta-
tion in the annealing region of one of these primers did 
not allow this product to amplify. Because of the high rate 
Table 4 Number of alleles and genetic diversity by locus by site
N number of samples that amplified per locus, Na number of alleles, MAF number of alleles at minor allele frequency (frequency less than 5 %), He unbiased expected 
heterozygosity
Pop Padrecocha San Jose de Lupuna Santo Tomas
Locus N Na MAF (%) He N Na MAF (%) He N Na MAF (%) He
MS1 70 5 2 (40) 0.659 55 6 4 (67) 0.52 63 6 4 (67) 0.467
MS2 77 7 4 (57) 0.651 56 8 3 (38) 0.812 64 8 3 (38) 0.8
MS3 84 2 0 (0) 0.413 53 6 2 (33) 0.761 72 4 2 (50) 0.476
MS4 86 9 4 (44) 0.826 55 6 3 (50) 0.71 77 9 4 (44) 0.822
MS5 87 4 2 (50) 0.539 56 2 0 (0) 0.341 78 2 0 (0) 0.399
MS6 74 7 2 (29) 0.811 53 6 1 (17) 0.816 77 6 2 (33) 0.766
MS7 77 5 3 (60) 0.536 56 4 3 (75) 0.17 66 3 2 (67) 0.296
MS8 74 11 4 (36) 0.873 49 12 6 (50) 0.854 76 13 7 (54) 0.841
MS9 72 11 3 (27) 0.894 53 9 2 (22) 0.864 73 12 5 (42) 0.866
MS10 85 12 8 (67) 0.734 49 11 5 (45) 0.838 58 13 8 (62) 0.817
MS12 81 11 7 (64) 0.779 52 13 4 (31) 0.912 76 10 4 (40) 0.838
MS15 84 8 3 (38) 0.81 55 7 3 (43) 0.789 75 7 3 (43) 0.739
MS16 70 18 9 (50) 0.902 48 15 7 (47) 0.895 62 15 6 (40) 0.901
MS20 82 8 2 (25) 0.844 55 12 3 (25) 0.905 68 13 4 (31) 0.9
Pv6635 84 12 4 (33) 0.891 54 9 4 (44) 0.82 73 9 4 (44) 0.814
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of missing data (more than 5 % for 13 of the 15 microsat-
ellites used) and the overestimation of diversity, more in-
depth analyses, such as pair-wise linkage disequilibrium 
and genetic differentiation between populations were not 
able to be performed since those could lead to erroneous 
interpretations.
Current malaria epidemiology research relies substan-
tially on the use of molecular markers to estimate the 
malaria transmission dynamics. For this reason, geno-
typing methods with low cost of reagents, high accuracy 
and repeatability are needed. Recently analysis of single 
nucleotide polymorphisms (SNPs) have been shown to 
reliably to infer malaria transmission patterns in hyper-
endemic regions [43]. However, in low transmission 
regions where the parasite diversity is low associated 
with a clonal expansion of parasites, microsatellites are 
still the primary tool for detecting the small differences 
between parasite strains so that one can correctly infer 
transmission dynamics and potential outcomes of control 
measures [7, 10, 11, 29].
The automated QIAxcel advanced system is marketed 
as a rapid, facile and low-cost method for genotyping. 
Its main advantage is that it not depends on labelled 
primers with fluorophores which reduce the cost of the 
genotyping process drastically. While a 100 nano moles 
of a common primer is around 10 dollars, just 10 nano 
moles of a labelled primer is around 80 dollars. This dif-
ference makes the QIAxcel System an attractive option, 
but due to this characteristic, it is not possible to run 
the size marker and the sample into the same well and 
just one well contain the size marker in a plate, and the 
other wells contain the samples and the alignment mark-
ers. This work shows that each independent capillary and 
cartridge has different patterns of migration, and that 
the variation of results increases over the time. This het-
erogeneity is supposed to be reduced with the use of an 
alignment marker that normalizes the pattern of migra-
tion of molecules between capillaries, cartridges and 
runs. As the alignment marker flanks the PCR product in 
a range of 600 nucleotides the normalization process is 
not accurate enough to differentiate products that differ 
in 3 bp.
Conclusion
The use of affordable platforms that can generate data 
from fast evolving molecular markers, such as micro-
satellites, could facilitate scaling up molecular epide-
miologic investigations in P. vivax and other eukaryotic 
pathogens. Several platforms and techniques have been 
used for this purpose; however, systematic assessment 
of the performance (precision, accuracy and reproduc-
ibility) of such systems is often lacking. This study found 
that one such system, the QIAxcel Advanced System, 
was not a reliable platform for P. vivax genotyping using 
microsatellites.
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